KR880003940Y1 - 구급용 반창고 - Google Patents
구급용 반창고 Download PDFInfo
- Publication number
- KR880003940Y1 KR880003940Y1 KR2019880012879U KR880012879U KR880003940Y1 KR 880003940 Y1 KR880003940 Y1 KR 880003940Y1 KR 2019880012879 U KR2019880012879 U KR 2019880012879U KR 880012879 U KR880012879 U KR 880012879U KR 880003940 Y1 KR880003940 Y1 KR 880003940Y1
- Authority
- KR
- South Korea
- Prior art keywords
- aid
- pad
- sheet
- adhesive tape
- blister
- Prior art date
Links
- 239000002390 adhesive tape Substances 0.000 title 1
- 239000003814 drug Substances 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 9
- 239000011248 coating agent Substances 0.000 claims description 8
- 238000000576 coating method Methods 0.000 claims description 8
- 239000000853 adhesive Substances 0.000 claims description 7
- 230000001070 adhesive effect Effects 0.000 claims description 7
- 238000009958 sewing Methods 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims 1
- 239000011505 plaster Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 5
- -1 chlor xylenol Chemical class 0.000 description 4
- 239000000645 desinfectant Substances 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N ethyl benzoate Chemical compound CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- SIACJRVYIPXFKS-UHFFFAOYSA-N (4-sulfamoylphenyl)methylazanium;chloride Chemical compound Cl.NCC1=CC=C(S(N)(=O)=O)C=C1 SIACJRVYIPXFKS-UHFFFAOYSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- BALXUFOVQVENIU-GNAZCLTHSA-N Ephedrine hydrochloride Chemical compound Cl.CN[C@@H](C)[C@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-GNAZCLTHSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- HCBIBCJNVBAKAB-UHFFFAOYSA-N Procaine hydrochloride Chemical compound Cl.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 HCBIBCJNVBAKAB-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- PPWHTZKZQNXVAE-UHFFFAOYSA-N Tetracaine hydrochloride Chemical compound Cl.CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 PPWHTZKZQNXVAE-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229940064734 aminobenzoate Drugs 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 description 1
- 229960003291 chlorphenamine Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 229960002534 ephedrine hydrochloride Drugs 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000011086 glassine Substances 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- AHXDSVSZEZHDLV-UHFFFAOYSA-N mesulfen Chemical compound CC1=CC=C2SC3=CC(C)=CC=C3SC2=C1 AHXDSVSZEZHDLV-UHFFFAOYSA-N 0.000 description 1
- 229960005479 mesulfen Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229960001309 procaine hydrochloride Drugs 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- YZMCKZRAOLZXAZ-UHFFFAOYSA-N sulfisomidine Chemical compound CC1=NC(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 YZMCKZRAOLZXAZ-UHFFFAOYSA-N 0.000 description 1
- 229960001975 sulfisomidine Drugs 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- GKCBAIGFKIBETG-UHFFFAOYSA-N tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 description 1
- 229960002494 tetracaine hydrochloride Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000003357 wound healing promoting agent Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0203—Adhesive bandages or dressings with fluid retention members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/58—Adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
내용 없음.
Description
제1도는 본 고안의 실시예를 나타내는 구급용 반창고의 평면도.
제2도는 제1도의 A-A'선 종단면도.
제3도는 다른 실시예를 나타내는 PTP(press-through pack) 박리 시이트의 평면도.
제4도 및 제5도는 또 다른 실시예를 나타내는 PTP박리 시이트의 종단면도.
* 도면의 주요부분에 대한 부호의 설명
1 : 점착성시이트 2 : 패드
3 : 약제 4 : 박리 시이트
6 : 블리스터부 8 : 재봉눈금
일반적으로 빈번하게 사용되는 간이 구급용 반창고는 살균소독제, 창상(創像) 치료제를 함침시킨 가아제를 통기공을 보유하는 점착성 시이트에 장착하고, 사용시에 이면의 박리지를 떼어내어 상기한 가아제부를 상처자리의 신체 일부분에 당접하여 사용하도록 한 것이다.
그러나, 이들의 종래품에 있어서는 사전에 가아제에 약액을 함침시켜 놓기 때문에 시간경과에 따라서 약액이 증발 비산되고, 또 효력의 활성이 상실됨을 초래할 뿐만 아니라 신체 일부분에의 당접에 즈음해서는 가아제부가 건조상태로 되기 때문에 상처자리를 손상시킬 염려가 있으며, 사용에 즈음해서도 아픔을 느끼게 되는 결점이 있었다.
본 고안의 상기한 결점을 해결한 것으로서, 패드를 장착한 점착성 시이트에 약제를 내포하는 블리스터부를 형성한 PTP박리 시이트로 접착한 것을 특징으로 하고 있다. 이하 도면을 참조하면서 본 고안에 대하여 상세히 설명한다. 제1도 및 제2도에 있어서, (1)은 패드(2)를 장착한 점착성 시이트이며, 패드상부에 약제(3)가 약제피복막(5)과 박리 시이트(4)에 설치된 블리스터부(6)로서 형성된 공간내에 내포되어 있다. 박리 시이트(4)의 단부에는 슬릿(7)이 각설되어 있다.
본원에 사용하는 약제에 대해서는 살균소독제로서 글루콘산 클로르 헥시딘, 염화 벤잘코늄, 클로르 크실레놀, 아크리늄, 티안톨, 염화 데칼리늄, 술피소미딘, 술파민, 니트로 푸라손, 붕산, 호모술파민, 트리클로 카르반등이 있으며, 창상부 수렴 치유촉진제로서 산화아연, 염화 피리독신, 초산 토코페롤, 디팔미틴산 피리독신 등, 지혈제로서 염화나파소민, 황산아연, 염산 에페드린 등, 항(抗) 염증제로서는 프레도니소론, 덱사메사손, 초산코르티손등의 스테로이드제, 글리틸레틴, 염화 리소자임 등, 항히스타민제로서 말레인산 클로로페니라민, 염산디펜히드라민 등이 있다. 또 국소 마취제로서는 리도카인, 아미노 안식향산 에틸, 염산 프로카인, 염산 디브카인, 염산 테트라카인, 염산 파라부틸 아미노 안식향산 디에틸 아미노 에틸등이 있다.
이들의 약제는 목적에 맞추어 단미(單味)로 또는 복수의 배합제로 할 수 있으며, 또 약제의 성상(性狀)은 용액상 이외에 연고상, 그리이스상, 분말 등 유동성이 있는 것이라면 어떠한 성상이라도 좋다. 점착성 시이트는 보통 사용되는 것으로서 좋고, 패드부는 탈지면, 기타 각종의 솜, 부직포 등을 사용할 수 있으며, 적당히 그 중앙부를 음푹 들어간 형상으로 할 수 있다. 또 보통의 방법에 의하여 이면을 방수처리하여도 좋다. 박리 시이트는 염화비닐수지, 기타 합성수지 등의 재질에 따라 성형되고, 중앙부에 원형, 타원형 혹은 구형상의 블리스터부를 설치하며, 또 박리 시이트를 떼어내기 용이하게 하기 위하여 단부에 슬릿을 설치하는 것이 좋다.
박리 시이트의 블리스터부 아래면에 약제를 사용할 때까지 패드에 접촉시키는 것을 방지하기 위한 약제 피복막이 시일되어 있다. 약제 피복막은 알루미늄 박, 그래신(glassine)지 등의 재질로서, 상기한 박리 시이트와 PTP포장되어 있으며, 본 고안 PTP박리 시이트를 형성한다.
그 피복막은 약제를 보호할 수 있는 크기면 좋으나, 점착성 시이트의 아래면 전체면에 설치되어 있어서 지장은 없다. 본 고안 구급용 반창고를 사용함에 즈음해서는 블리스터부(6)를 손가락으로 압압하여서 약제 피복막(5)을 파괴하는 것에 의하여 약제(3)가 패드(2)위로 유동한다.
이어서, 슬릿(7)을 절곡하여 박리시이트(4)를 점착성 시이트(1)에서 떼어내는 것에 의하여 사용시 항상 신선한 약제가 스며나온 패드의 창상면에 당접 사용할 수 있으므로 약제의 효력을 손상시키는 일없이 또 상처자리를 손상되는 일없이 사용할 수가 있다. 또한, 약제의 효력을 장기간 보전 유지할 수 있으므로 살균, 소독, 치료의 소망하는 목적달성에 유효하다.
또, 본 고안 다른 실시예로서 제3도에 표시하는 바와같이 PTP박리 시이트의 블리스터부의 양쪽에 재봉눈금(8)을 설치하여 놓으면, 블리스터부의 절곡 혹은 압압시에 약제 피복막이 무리없이 파괴되어 그 피복막이 패드위에 남아 있는 일은 없다. 또한 제4도 및 제5도에 표시하는 바와 같이 변형 블리스터부 혹은 슬릿이 부착된 약제 피복막을 사용하는 것에 의하여 약제 피복막의 파괴가 용이하게 된다.
Claims (4)
- 패드(2)를 장착한 점착성 시이트(1)에 약제(3)를 내포하는 블리스터부(6)를 형성한 PTP박리 시이트(4)로 접착한 것을 특징으로 하는 구급용 반창고.
- 제1항에 있어서, 상기한 블리스터부(6)의 양쪽에 재봉눈금(8)을 설치한 것을 특징으로 하는 구급용 반창고.
- 제1항에 있어서, 상기한 블리스터부(6)에 오목부를 설치한 것을 특징으로 하는 구급용 반창고.
- 제3항에 있어서, 약제 피복막(5)에 슬릿이 설치된 것을 특징으로 하는 구급용 반창고.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR2019880012879U KR880003940Y1 (ko) | 1981-12-09 | 1988-08-03 | 구급용 반창고 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19887981A JPS5899957A (ja) | 1981-12-09 | 1981-12-09 | 救急バンデ−ジ |
| JP56-198879 | 1981-12-09 | ||
| KR1019820005500A KR840002646A (ko) | 1981-12-09 | 1982-12-08 | 구급용 반창고 |
| KR2019880012879U KR880003940Y1 (ko) | 1981-12-09 | 1988-08-03 | 구급용 반창고 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019820005500A Division KR840002646A (ko) | 1981-12-09 | 1982-12-08 | 구급용 반창고 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR880003940Y1 true KR880003940Y1 (ko) | 1988-11-09 |
Family
ID=27327563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR2019880012879U KR880003940Y1 (ko) | 1981-12-09 | 1988-08-03 | 구급용 반창고 |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR880003940Y1 (ko) |
-
1988
- 1988-08-03 KR KR2019880012879U patent/KR880003940Y1/ko not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR880003941Y1 (ko) | 구급용 반창고 | |
| US6120792A (en) | Medicated skin patch and method for its use | |
| JP2513712B2 (ja) | 創傷用ドレッシング | |
| US3328259A (en) | Dressing for a wound containing a hemostatic agent and method of treating a wound | |
| US4134399A (en) | Skin protective device | |
| US20090099496A1 (en) | Pressure bandage with medication delivery system | |
| US3366112A (en) | Adhesive bandage having container of liquid medicament | |
| US20080027365A1 (en) | Hemostatic device with oxidized cellulose pad | |
| US4000737A (en) | Surgical incision shield | |
| US4788061A (en) | Extended occlusive treatment of skin disorders | |
| PT868159E (pt) | Dispositivo de proteccao corporal com ajuste personalizado e reforco variavel | |
| EP0297828A1 (en) | Novel medicated dressings | |
| US3297032A (en) | Adhesive bandage having container of medicament carried by removable protector strip | |
| KR880003940Y1 (ko) | 구급용 반창고 | |
| JPH0157580B2 (ko) | ||
| WO2007048171A1 (en) | A medicated dressing for wound healing | |
| JPH0136519Y2 (ko) | ||
| US797094A (en) | Surgical bandage-plaster. | |
| JP4136182B2 (ja) | 救急用絆創膏 | |
| CN215229247U (zh) | 皮肤包覆敷贴 | |
| JPH0529463B2 (ko) | ||
| JPH0534649Y2 (ko) | ||
| JPH0432099Y2 (ko) | ||
| JPS61222451A (ja) | 救急絆創膏 | |
| JPS63119764A (ja) | 救急絆創膏 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E701 | Decision to grant or registration of patent right | ||
| REGI | Registration of establishment | ||
| J202 | Request for trial for correction [limitation] | ||
| J801 | Dismissal of trial |
Free format text: DISMISSAL OF TRIAL FOR CORRECTION REQUESTED 19900627 Effective date: 19900928 |
|
| FPAY | Annual fee payment |
Payment date: 19941018 Year of fee payment: 7 |
|
| EXPY | Expiration of term |